


<?phpxml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
>
<channel>
<title>Dofollow Social Bookmarking Sites 2016 / bebetterpharmacy / Published News</title>
<link>http://www.future.ipt.pw</link>
<description>Your Source for Social News and Networking</description>
<pubDate>Wed, 08 Jan 2025 03:32:33 +0000</pubDate>
<language>en</language>
<item>
	<title><![CDATA[Yaz 0.02mg/3mg]]></title>
	<link>http://www.future.ipt.pw/News/yaz-0-02mg3mg/</link>
	<source url="http://www.future.ipt.pw/News/yaz-0-02mg3mg/"><![CDATA[Yaz 0.02mg/3mg]]></source>
	<description><![CDATA[Yaz 0.02mg/3mg is a combination oral contraceptive designed to prevent pregnancy and regulate menstrual cycles. It contains two active ingredients: ethinyl estradiol (0.02 mg) and drospirenone (3 mg). This medicine not only provides reliable contraception but may also help reduce symptoms of premenstrual dysphoric disorder (PMDD), treat moderate acne in women, and stabilize hormonal imbalances.<br /><br />Inform your doctor if you have a history of blood clots, liver disease, or breast cancer.<br />Avoid smoking while using Yaz, as it increases the risk of cardiovascular side effects, especially in women over 35.<br />Do not use if you are pregnant or suspect you may be pregnant.<br />Inform your healthcare provider about all medications you are taking to avoid potential interactions.<br />Regularly monitor blood pressure and consult your doctor for routine checkups. ]]></description>
	<pubDate>Wed, 08 Jan 2025 03:32:33 +0000</pubDate>
	<author>bebetterpharmacy</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.future.ipt.pw/News/yaz-0-02mg3mg/</guid>
</item>

<item>
	<title><![CDATA[Erlocip 100mg]]></title>
	<link>http://www.future.ipt.pw/News/erlocip-100mg/</link>
	<source url="http://www.future.ipt.pw/News/erlocip-100mg/"><![CDATA[Erlocip 100mg]]></source>
	<description><![CDATA[Erlocip 100mg contains Erlotinib as its active ingredient and is used for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. This medication works by inhibiting the growth of cancer cells, targeting specific proteins responsible for their proliferation. Erlocip 100mg is a trusted option prescribed by doctors to manage certain cancers effectively.<br /><br />Inform your doctor about any pre-existing conditions, such as liver or kidney issues.<br />Avoid taking this medicine during pregnancy or breastfeeding without consulting a doctor.<br />Refrain from smoking as it can reduce the effectiveness of the medication.<br />Stay hydrated and avoid prolonged sun exposure, as the medicine may make your skin more sensitive.<br />Keep your doctor informed about any ongoing medications or supplements to prevent drug interactions. ]]></description>
	<pubDate>Thu, 02 Jan 2025 07:09:20 +0000</pubDate>
	<author>bebetterpharmacy</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.future.ipt.pw/News/erlocip-100mg/</guid>
</item>

</channel>
</rss>
